Frontlight ResearchEarly access
Trial site
Kawasaki
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy3 trials
- Childhood cancers2 trials
- Coronary artery disease2 trials
- Stroke2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Status
- Completed5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals11 trials
Running trials
Active, not recruiting
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
Closed trials
Completed
Terminated
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026